Dr. Ronald Cotton, Dr. Jayer Chung, Dr. N. Thao N. Galvan and Dr. George Van Buren II were recently inducted into the Texas Surgical Society as fellows during the 2021 Fall Hybrid Meeting in San Antonio, Texas, held Oct. 8-10. New membership in the TSS is by nomination and endorsement by three fellows of the society, followed by proposal by council for the vote sheet and finally election by general membership.
Dr. Ronald Cotton, associate professor of surgery in the Division of Abdominal Transplantation, specializes in liver and kidney transplantation. He has a strong interest in undergraduate and post-graduate medical education, where he is especially interested in improving access for all learners interested in careers in surgery. His clinical philosophy centers upon the delivery of technically and clinically exceptional surgical care in a personal, compassionate manner.
Dr. Jayer Chung, assistant professor of surgery in the Division of Vascular Surgery & Endovascular Therapy, specializes in the latest endovascular techniques as well as traditional open vascular surgery. He has a strong clinical interest limb salvage, diabetic foot ulceration, carotid occlusive disease, thoracic and abdominal aortic aneurysmal disease, aortic graft infections, renovascular hypertension, mesenteric ischemia, venous and arterial thoracic outlet syndrome, and chronic deep venous thrombosis.
Dr. George Van Buren II, associate professor of surgery in the Division of Surgical Oncology, specializes in surgical oncology and pancreatic disorders. He has a strong interest in pancreatic and gastric malignancies, and his goals are to provide high-quality clinical care while offering his patients access to innovative clinical and therapeutic trials.
Dr. N. Thao N. Galvan, assistant professor of surgery in the Division of Abdominal Transplantation, specializes in adult and pediatric liver and kidney transplantations. She has a strong interest in solid organ transplantation outcomes, ethics and surgical technique—especially focused on the pediatric transplant population—and additive bioengineering and its potential for transplant medicine.